Three lessons from Pharmanovia’s ESG Report
Neeshe Williams, General Counsel and Head of ESG at Pharmanovia opines that the pharma industry has renewed its focus on…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Supriya Lifescience, Plasma Nutrition to collaborate for protein technology
During the term of the agreement, Supriya Lifescience will lead the manufacturing and marketing of ioProtein in India
Centhaquine set to enter US-FDA approved Phase 3 clinical trial in US and Europe
Pharmazz India obtained marketing authorization for the management of Hypovolemic shock Lyfaquin (INN: Centhaquine) in India in…
Lupin US FDA approval for Fluocinolone Acetonide Topical Oil
This product will be manufactured at Lupin’s Somerset facility in the US
Boehringer’s Cyltezo illustrates intersection of price and regulation in biosimilar market: …
Of all the adalimumab biosimilars, Cyltezo is of note due to the company taking the extra and uncommon step of showing…
Lupin gets US FDA approval for Norgestrel and Ethinyl Estradiol Tablets USP
This product will be manufactured at Lupin’s Pithampur facility in India.
Janssen’s JNJ-2113 holds potential to become leading treatment for psoriasis: GlobalData
JNJ-2113, a novel, first-in-class oral interleukin 23 receptor (IL-23R) antagonist peptide in adult patients with…
GCV Life launches its new website GCVideal
With the unveiling of their website, GCVideal aims to offer a seamless experience for individuals and organisations seeking…
Novo Nordisk sponsors 10 school students to be part of its Future Scientists Summer Camp
This week-long summer camp will host 100 exceptional students coming together from across the world
Glenmark gets ANDA approval for Saxagliptin Tablets, 2.5 mg and 5 mg
Glenmark’s Saxagliptin Tablets, 2.5 mg and 5 mg, will be distributed in the US by Glenmark Pharma, USA
Venus Remedies gets marketing authorisation for cancer drugs from Philippines, Paraguay, Georgia and…
With this, the number of marketing approvals for its oncology products across 76 countries has gone up to 506
Lupin announces resolution of USFDA warning letter for its two facilities
This is after the satisfactory evaluation of the corrective actions taken by the company in response to the warning letter that…
Merck and Moderna initiate phase 3 study evaluating V940
V940-001 is the first phase 3 study of a planned comprehensive clinical development program being initiated following the positive…
Indoco’s Baddi facility receives GMP certification from EU Health Authority
The Agency had conducted an inspection at Indoco’s manufacturing facility for solid oral dosage form from April 20 - 24, 2023
Shingles vaccine reduces risk of stroke and heart attack from virus: Study
Results are based on analysis of data from 278,375 adults in New Zealand who got the vaccine between April 2018 and July 2021.…
Lupin receives approval from TGA Australia for Tiotropium dry powder
The product will be manufactured at Lupin’s Pithampur facility in India
GSK announces financial results for Q2 2023
Profit After Tax (PAT) for the quarter at Rs 131 crores grew by ~ 13 per cent
Pharma industry headwinds in remission: ICRA
Revenues of ICRA’s sample set to grow by 7-9 per cent in FY2024; OPM to stabilise at 20.5-21.5 per cent in FY2024
BSV launches ART Act Readiness Assessment Program with Bureau Veritas (India)
It will enable ART centres/clinics to implement the requirements of the Assisted Reproductive Technology Regulations, 2021 for…
AstraZeneca’s Dapagliflozin gets extended indication approval from DCGI to treat heart failure in…
The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted…